Unrelated donor hematopoietic stem cell transplantation for acute leukemia with invasive fungal infection:Two cases report and literature review
-
[1] 中国侵袭性真菌感染工作组.血液病/恶性肿瘤患者侵袭性真菌病的诊断标准与治疗原则 (第四次修订版)[J].中华内科杂志, 2013, 52 (8):710-711.
[2] Maziarz RT, Brazauskas R, Chen M, et al.Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies:a CIBMTR study[J].Bone Marrow Transplant, 2016, 52:270-278.
[3] Liu Q, Lin R, Sun J, et al.Antifungal agents for secondary prophylaxis based on response to initial antifungal therapy in allogeneic hematopoietic stem cell transplant recipients with prior pulmonary aspergillosis[J].Biol Blood Marrow Transplant, 2014, 20:1198-1203.
[4] Azik FM, Tezer H, Parlakay AO, et al.Secondary antifungal prophylaxis in pediatric hematopoietic stem cell transplants[J].J Pediatr Hematol Oncol, 2015, 37:19-22.
[5] de Fabritiis P, Spagnoli A, Bartolomeo PD, et al.Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infection[J].Bone Marrow Transplant, 2007, 40:245-249.
[6] Lei G, Sun Y, Meng F, et al.Antifungal prophylaxis of patients undergoing allogenetic hematopoietic stem cell transplantation in China:a multicenter prospective observational study[J].J Hematol Oncol, 2016, 9:97.
[7] Liu F, Wu T, Wang JB, et al.Risk factors for recurrence of invasive fungal infection during secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients[J].Transpl Infect Dis, 2013, 15:243-250.
计量
- 文章访问数: 255
- PDF下载数: 86
- 施引文献: 0